SPDR S&P Biotech ETF $XBI Stock: Kestra Advisory Services LLC Raises Holdings

Kestra Advisory Services LLC raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,932 shares of the exchange traded fund’s stock after acquiring an additional 4,272 shares during the period. Kestra Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $4,720,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Commonwealth Equity Services LLC increased its position in shares of SPDR S&P Biotech ETF by 16.6% during the 3rd quarter. Commonwealth Equity Services LLC now owns 95,742 shares of the exchange traded fund’s stock valued at $15,097,000 after purchasing an additional 13,623 shares during the period. Kestra Private Wealth Services LLC boosted its position in shares of SPDR S&P Biotech ETF by 4.5% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 9,257 shares of the exchange traded fund’s stock valued at $1,460,000 after purchasing an additional 397 shares in the last quarter. Chicago Partners Investment Group LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $241,000. Lyell Wealth Management LP raised its holdings in shares of SPDR S&P Biotech ETF by 22.8% in the 3rd quarter. Lyell Wealth Management LP now owns 33,000 shares of the exchange traded fund’s stock worth $5,203,000 after purchasing an additional 6,119 shares in the last quarter. Finally, Associated Banc Corp acquired a new stake in SPDR S&P Biotech ETF during the third quarter valued at approximately $1,047,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $151.20 on Friday. The stock has a market capitalization of $10.24 billion, a P/E ratio of 20.64 and a beta of 0.87. SPDR S&P Biotech ETF has a 1 year low of $111.11 and a 1 year high of $169.89. The business’s fifty day moving average is $154.54 and its two-hundred day moving average is $142.81.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.